Author(s) :
Andrada Olivia Țăpîrdea¹, Teodor Marian Vancea¹, Bogdan Cristian Venter¹, Octavia Bristena Terțan², Annamaria Patka², Claudia Cristina Burz¹,²
¹ Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca,
² Oncology Institute of Cluj-Napoca
Corresponding author: Andrada Olivia Țăpîrdea, Email: tapirdeaandrada@gmail.com
Published: Volume IV, Issue 1, 29 July 2024, 45 - 50 DOI: 10.53011/JMRO.2024.01.06
Abstract
Breast cancer is, due to its high incidence rate, one of the most studied malignancies in medical research nowadays. Thus, well-established screening schedules, targeted medical treatment options and surgical innovations are evolving at a high pace, some aspects are not yet generally concluded and one of them is the issue of late recurrence. Our case presents a patient with a 35-year relapse window after a curatively treated invasive mammary carcinoma and aspects such as the diagnostic process, therapeutical management, and immediate outcome are extensively described. Several key aspects of this issue are discussed as a brief review of the literature.
